275 related articles for article (PubMed ID: 16414339)
1. Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century.
Ganz PA
Am J Med; 2005 Dec; 118 Suppl 12B():136-41. PubMed ID: 16414339
[TBL] [Abstract][Full Text] [Related]
2. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Knobf MT
Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
[TBL] [Abstract][Full Text] [Related]
3. Nonhormonal alternatives for the management of early menopause in younger women with breast cancer.
Bachmann GA
J Natl Cancer Inst Monogr; 1994; (16):161-7. PubMed ID: 7999460
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
5. Management of postmenopausal symptoms in breast cancer survivors.
Bruno D; Feeney KJ
Semin Oncol; 2006 Dec; 33(6):696-707. PubMed ID: 17145350
[TBL] [Abstract][Full Text] [Related]
6. Overview of long term care of breast cancer survivors.
Brennan ME; Houssami N
Maturitas; 2011 Jun; 69(2):106-12. PubMed ID: 21489727
[TBL] [Abstract][Full Text] [Related]
7. Symptoms and treatment in cancer therapy-induced early menopause.
Boekhout AH; Beijnen JH; Schellens JH
Oncologist; 2006 Jun; 11(6):641-54. PubMed ID: 16794243
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and women with premature menopause--a cancer survivorship issue.
King J; Wynne CH; Assersohn L; Jones A
Eur J Cancer; 2011 Jul; 47(11):1623-32. PubMed ID: 21561765
[TBL] [Abstract][Full Text] [Related]
9. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?
Trinkaus M; Chin S; Wolfman W; Simmons C; Clemons M
Oncologist; 2008 Mar; 13(3):222-31. PubMed ID: 18378532
[TBL] [Abstract][Full Text] [Related]
10. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.
Schover LR
J Clin Oncol; 2008 Feb; 26(5):753-8. PubMed ID: 18258983
[TBL] [Abstract][Full Text] [Related]
11. The menopausal symptom experience in young mid-life women with breast cancer.
Knobf MT
Cancer Nurs; 2001 Jun; 24(3):201-10; quiz 210-1. PubMed ID: 11409064
[TBL] [Abstract][Full Text] [Related]
12. [Sexual functioning and information needs in women with premature menopause following breast cancer treatment].
Mannor B; Zohar H
Harefuah; 2006 Feb; 145(2):90-4, 168. PubMed ID: 16509409
[TBL] [Abstract][Full Text] [Related]
13. Natural menopause and ovarian toxicity associated with breast cancer therapy.
Knobf MT
Oncol Nurs Forum; 1998 Oct; 25(9):1519-30; quiz 1531-2. PubMed ID: 9802049
[TBL] [Abstract][Full Text] [Related]
14. Fertility and adjuvant treatment in young women with breast cancer.
Partridge AH; Ruddy KJ
Breast; 2007 Dec; 16 Suppl 2():S175-81. PubMed ID: 17804236
[TBL] [Abstract][Full Text] [Related]
15. The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study.
Thewes B; Meiser B; Rickard J; Friedlander M
Psychooncology; 2003; 12(5):500-11. PubMed ID: 12833562
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for premenopausal patients with early breast cancer.
Kurebayashi J
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):51-4. PubMed ID: 18197006
[TBL] [Abstract][Full Text] [Related]
17. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.
Duffy CM; Allen SM; Clark MA
J Clin Oncol; 2005 Feb; 23(4):766-73. PubMed ID: 15681520
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
19. The management of menopausal symptoms in breast cancer survivors: case-based approach.
Lammerink EA; de Bock GH; Schröder CP; Mourits MJ
Maturitas; 2012 Nov; 73(3):265-8. PubMed ID: 22883373
[TBL] [Abstract][Full Text] [Related]
20. Hormonal breast cancer agents: implications for the primary care provider.
Lyon DE; Roux G; Voll S
J Am Acad Nurse Pract; 2006 Nov; 18(11):518-23. PubMed ID: 17064329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
